scholarly journals Treatment of post-cholecystectomy biliary strictures with fully-covered self-expanding metal stents – results after 5 years of follow-up

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Andrea Tringali ◽  
◽  
D. Nageshwar Reddy ◽  
Thierry Ponchon ◽  
Horst Neuhaus ◽  
...  

Abstract Background Endoscopic treatment of post-cholecystectomy biliary strictures (PCBS) with multiple plastic biliary stents placed sequentially is a minimally invasive alternative to surgery but requires multiple interventions. Temporary placement of a single fully-covered self-expanding metal stent (FCSEMS) may offer safe and effective treatment with fewer re-interventions. Long-term effectiveness of treatment with FCSEMS to obtain PCBS resolution has not yet been studied. Methods In this prospective multi-national study in patients with symptomatic benign biliary strictures (N = 187) due to various etiologies received a FCSEMS with scheduled removal at 6–12 months and were followed for 5 years. We report here long-term outcomes of the subgroup of patients with PCBS (N = 18). Kaplan Meier analyses assessed long-term freedom from re-stenting. Adverse events were documented. Results Endoscopic removal of the FCSEMS was achieved in 83.3% (15/18) of patients after median indwell of 10.9 (range 0.9–13.8) months. In the remaining 3 patients (16.7%), the FCSEMS spontaneously migrated and passed without complications. At the end of FCSEMS indwell, 72% (13/18) of patients had stricture resolution. At 5 years after FCSEMS removal, 84.6% (95% CI 65.0–100.0%) of patients who had stricture resolution at FCSEMS removal remained stent-free. In addition, at 75 months after FCSEMS placement, the probability of remaining stent-free was 61.1% (95% CI 38.6–83.6%) for all patients. Stent or removal related serious adverse events occurred in 38.9% (7/18) all resolved without sequalae. Conclusions In patients with symptomatic PCBS, temporary placement of a single FCSEMS intended for 10–12 months indwell is associated with long-term stricture resolution up to 5 years. Temporary placement of a single FCSEMS may be considered for patients with PCBS not involving the main hepatic confluence. Trial registration numbers NCT01014390; CTRI/2012/12/003166; Registered 17 November 2009.

Endoscopy ◽  
2004 ◽  
Vol 36 (05) ◽  
pp. 381-384 ◽  
Author(s):  
A. van Berkel ◽  
D. Cahen ◽  
D. van Westerloo ◽  
E. Rauws ◽  
K. Huibregtse ◽  
...  

Endoscopy ◽  
2016 ◽  
Vol 48 (05) ◽  
pp. 447-447 ◽  
Author(s):  
Jin-Seok Park ◽  
Sang Lee ◽  
Tae Song ◽  
Do Park ◽  
Dong-Wan Seo ◽  
...  

Endoscopy ◽  
2020 ◽  
Vol 52 (05) ◽  
pp. 368-376 ◽  
Author(s):  
Tatsuya Sato ◽  
Hirofumi Kogure ◽  
Yousuke Nakai ◽  
Kazunaga Ishigaki ◽  
Ryunosuke Hakuta ◽  
...  

Abstract Background While endoscopic management of benign biliary strictures (BBSs) is the standard of care, long-term treatment remains the issue in refractory cases, especially for anastomotic strictures after living-donor liver transplantation (LDLT) and hepaticojejunostomy anastomotic strictures (HJAS). The aim of this prospective study was to evaluate the safety and effectiveness of a fully covered self-expandable metal stent (FCSEMS) for patients with refractory BBSs. Methods Patients with BBSs that were unamenable to endoscopic plastic stent placement with a treatment period of more than 6 months were eligible. An FCSEMS was placed endoscopically and removed after 90 days. In patients with surgically altered anatomy, an FCSEMS was placed using a double-balloon endoscope. The primary outcome was stricture resolution at FCSEMS removal. The secondary outcomes included stricture recurrence and adverse events. Results A total of 30 patients were enrolled: the causes of their BBSs were anastomotic stricture after LDLT in 13, HJAS in 12, post-cholecystectomy in two, chronic pancreatitis in two, and post-hepatectomy in one. The technical success rate of FCSEMS placement was 100 % and all FCSEMSs were successfully removed. The rate of stricture resolution at FCSEMS removal was 96.6 % (91.7 % in the post-LDLT group and 100 % in the HJAS group). Stricture recurrence occurred in three HJAS patients (10.7 %) during a median follow-up period of 15.6 months. Adverse events were observed in 12.1 %: five cholangitis, one pancreatitis, and one perforation. Conclusion Temporary placement of an FCSEMS was a feasible and effective treatment option for refractory BBSs, especially for post-LDLT strictures and HJAS.


2007 ◽  
Vol 65 (5) ◽  
pp. AB123
Author(s):  
Michel Kahaleh ◽  
Brian W. Behm ◽  
Bridger W. Clarke ◽  
Andrew Brock ◽  
Vanessa M. Shami ◽  
...  

2013 ◽  
Vol 47 (8) ◽  
pp. 695-699 ◽  
Author(s):  
Michel Kahaleh ◽  
Alan Brijbassie ◽  
Amrita Sethi ◽  
Marisa DeGaetani ◽  
John M. Poneros ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document